OTCPK:HALB - Post by User
Post by
AveragePennyon Mar 01, 2022 10:53am
50 Views
Post# 34471082
$HALB Halberd's COVID-19 Antibody is the Only One
$HALB Halberd's COVID-19 Antibody is the Only One JACKSON CENTER, PA / ACCESSWIRE / March 1, 2022 / Halberd Corporation's (OTC PINK:HALB) previously developed SARS-CoV-2 antibody demonstrated superior binding capability to the SARS-CoV-2 Omicron variant disease antigen. The Halberd antibody was tested against monoclonal antibodies which are biosimilar to five FDA approved Emergency Use Authorization (EUA) COVID antibodies. The results are shown on the graph below.
On the vertical axis is the Absorbance (a measure of binding capability) of the various monoclonal antibodies (mAbs) to the Omicron variant disease antigen, and the antibody concentration (dose) is shown on the horizontal axis.
Halberd's antibody is depicted as 11D7, as highlighted on the graph. It reveals that with increased concentrations of the antibody, the binding capability increases. The other five (approved mAbs) have near zero binding, regardless of concentration.
https://www.accesswire.com/690803/halberds-covid-19-antibody-is-the-only-one-in-competitive-tests-to-bind-to-omicron-variant